Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
2
×
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acetylon pharmaceuticals
alder biopharmaceutical
allergan
ambys medicines
american academy of neurology
amgen
atogepant
biohaven
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cell therapy
clinical trials
constellation pharmaceuticals
deals
detroit blog main
detroit top stories
drugs
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
gene therapy
What
big
2
×
make
2
×
new
aiming
ambys
approval
arguments
biotech
class
commercialized
companies
competitors
control
deadly
deal
debuted
decades
diseases
drug
drugs
fda
formed
future
launch
liver
medicines
meeting
migraine
neuro
oral
potential
startup
takeda
therapies
today
treatments
unusual
variety
won
year
Language
Current search:
big
×
make
×
" national top stories "
×
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
